Post‐Translational Modifications of RNA‐Modifying Proteins in Cellular Dynamics and Disease Progression
Yunfan Lin,Pei Lin,Ye Lu,Jiarong Zheng,Yucheng Zheng,Xiangyu Huang,Xinyuan Zhao,Li Cui
DOI: https://doi.org/10.1002/advs.202406318
IF: 15.1
2024-10-10
Advanced Science
Abstract:Post‐translational modifications (PTMs) of RNA‐modifying proteins, such as METTL3 and METTL14, modulate their activity and interactions, impacting transcription, signaling pathways, and immune responses. These processes are crucial in driving cancer progression, immune evasion, and pathogen responses, making PTMs of RNA modifiers potential therapeutic targets for clinical intervention in various diseases. This underscores their significance in both cellular dynamics and disease treatment strategies. RNA‐modifying proteins, classified as "writers," "erasers," and "readers," dynamically modulate RNA by adding, removing, or interpreting chemical groups, thereby influencing RNA stability, functionality, and interactions. To date, over 170 distinct RNA chemical modifications and more than 100 RNA‐modifying enzymes have been identified, with ongoing research expanding these numbers. Although significant progress has been made in understanding RNA modification, the regulatory mechanisms that govern RNA‐modifying proteins themselves remain insufficiently explored. Post‐translational modifications (PTMs) such as phosphorylation, ubiquitination, and acetylation are crucial in modulating the function and behavior of these proteins. However, the full extent of PTM influence on RNA‐modifying proteins and their role in disease development remains to be fully elucidated. This review addresses these gaps by offering a comprehensive analysis of the roles PTMs play in regulating RNA‐modifying proteins. Mechanistic insights are provided into how these modifications alter biological processes, contribute to cellular function, and drive disease progression. In addition, the current research landscape is examined, highlighting the therapeutic potential of targeting PTMs on RNA‐modifying proteins for precision medicine. By advancing understanding of these regulatory networks, this review seeks to facilitate the development of more effective therapeutic strategies and inspire future research in the critical area of PTMs in RNA‐modifying proteins.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry